Reply to "Comment on Casiraghi et al. 'Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis' 2020, 12, 211"

Antonella Casiraghi; Chiara Grazia Gennari; Umberto Maria Musazzi; Marco Aldo Ortenzi; Susanna Bordignon; Paola Minghetti

doi:10.3390/pharmaceutics12090822

Reply to "Comment on Casiraghi et al. 'Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis' 2020, 12, 211"

Pharmaceutics. 2020 Aug 28;12(9):822. doi: 10.3390/pharmaceutics12090822.

Authors

Antonella Casiraghi¹, Chiara Grazia Gennari¹, Umberto Maria Musazzi¹, Marco Aldo Ortenzi^{2

3}, Susanna Bordignon⁴, Paola Minghetti¹

Affiliations

¹ Department of Pharmaceutical Sciences, Via G. Colombo 71-20133 Milan, Italy.
² CRC Materiali Polimerici (LaMPo), Department of Chemistry, Università degli Studi di Milano, Via Golgi 19-20133 Milan, Italy.
³ Department of Chemistry, Università degli Studi di Milano, Via Golgi 19-20133 Milan, Italy.
⁴ Student of Specialization School in Pharmacy, Department of Pharmaceutical Sciences, Via G. Colombo 71-20133 Milan, Italy.

Abstract

The paper entitled "Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis Pharmaceutics 2020, 12, 211" discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis [...].